B39.3 Disseminated histoplasmosis capsulati

Name of the Condition

• Common Name(s): Disseminated Histoplasmosis
• Technical Term: Disseminated histoplasmosis capsulati

Summary

Disseminated histoplasmosis capsulati is a severe fungal infection caused by the Histoplasma capsulatum fungus, where the infection spreads beyond the lungs to other organs or systems. This condition occurs when the fungus disseminates through the bloodstream or lymphatic system, often affecting immunocompromised individuals. Symptoms vary based on the organs involved and the severity of the infection.

Causes

Disseminated histoplasmosis capsulati is caused by inhaling spores of the Histoplasma capsulatum fungus, which is commonly found in environments contaminated with bird or bat droppings, such as caves, old buildings, or soil. The spores become airborne when these areas are disturbed, leading to inhalation and subsequent infection. The disseminated form typically arises when the immune system cannot contain the infection, allowing it to spread throughout the body.

Risk Factors

• Living or traveling in endemic areas (e.g., Ohio and Mississippi River valleys)
• Exposure to bird or bat droppings
• Activities like spelunking, demolition, or handling soil that may lead to spore inhalation
• Weakened immune system (e.g., HIV/AIDS, chemotherapy, organ transplant)
• Untreated or severe pulmonary histoplasmosis

Symptoms

• Fever
• Fatigue
• Weight loss
• Cough (may be present if lungs are involved)
• Shortness of breath
• Abdominal pain or swelling
• Skin lesions or rashes
• Enlarged liver or spleen
• Neurological symptoms (e.g., confusion, headache) if the central nervous system is affected

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. Chest X-rays or CT scans may reveal lung abnormalities or signs of systemic involvement. Laboratory tests include fungal cultures, antigen detection in blood or urine, and histopathological examination of tissue samples. Biopsies of affected organs (e.g., liver, bone marrow) may be performed to confirm the presence of the fungus. Serological tests can also aid in diagnosis, particularly in endemic regions.

Treatment Options

Treatment typically involves antifungal medications, such as amphotericin B (for severe cases) followed by itraconazole or fluconazole for maintenance therapy. The duration of treatment depends on the severity of the infection and the patient's immune status. In immunocompromised patients, long-term suppressive therapy may be necessary to prevent recurrence. Supportive care, including oxygen therapy or management of organ-specific complications, may also be required.

Prognosis and Follow-Up

Prognosis varies based on the patient's immune status and the extent of organ involvement. With prompt and appropriate treatment, many patients recover, but disseminated histoplasmosis can be life-threatening, especially in immunocompromised individuals. Follow-up care includes monitoring for recurrence, assessing treatment response, and managing any residual organ damage. Regular clinical evaluations and imaging may be recommended to ensure the infection is fully resolved.

Complications

• Respiratory failure
• Organ dysfunction (e.g., liver, kidney, or adrenal gland involvement)
• Meningitis or other central nervous system infections
• Sepsis
• Chronic fatigue or persistent symptoms

Lifestyle & Prevention

• Avoid exposure to environments with high levels of bird or bat droppings, such as caves or old buildings.
• Wear protective masks or respirators when working in areas with potential fungal spore exposure.
• Maintain a healthy immune system through proper nutrition, exercise, and management of underlying conditions.
• Seek prompt medical attention if symptoms of respiratory infection occur after potential exposure.

When to Seek Professional Help

Seek immediate medical care if you experience severe symptoms such as high fever, difficulty breathing, unexplained weight loss, or signs of organ involvement (e.g., abdominal pain, jaundice, or neurological changes). Individuals with weakened immune systems should consult a healthcare provider if they suspect exposure to Histoplasma capsulatum, even if symptoms are mild.

Tips for Medical Coders

When coding for disseminated histoplasmosis capsulati (ICD-10-CM code B39.3), ensure documentation supports the systemic spread of the infection beyond the lungs. Verify that the medical record includes details about affected organs, diagnostic test results, and treatment plans. Accurate coding requires clear differentiation from localized or pulmonary forms of histoplasmosis. Review clinical notes for evidence of dissemination, such as positive cultures from multiple sites or imaging showing widespread involvement.